Trials / Completed
CompletedNCT04672642
Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations
Evaluation of the SpyGlass DS vs Standard Method for Detection of Residual Pancreatic Calculations After Endoscopic Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Hospital St. Joseph, Marseille, France · Academic / Other
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SpyGlass DS | Detection by the SpyGlass DS of residual pancreatic stones not detected by the standard method (CT scan and ERCP) |
Timeline
- Start date
- 2021-07-12
- Primary completion
- 2024-03-13
- Completion
- 2024-03-13
- First posted
- 2020-12-17
- Last updated
- 2024-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04672642. Inclusion in this directory is not an endorsement.